BILLS-107hr4013enr.pdf

fiscal year 2002 each of the fiscal years 2003 through 2006 biennially 1983 Wednesday more than 5 years annual many years 2002 5 years the 1970s 1993 twenty-third day of January

the ‘‘Rare Diseases Act

the United States the City of Huntington United States of America the United States of America United States Washington the United States

Americans

the National Institutes of Health SEC the Public Health Service Act Congress NIH Senate Drug Administration the National Institutes of Health the ‘Office’ MENTS House of Representatives the Office of Rare Diseases The Office of Rare Diseases the Office of the Director an Office of Rare Diseases the Department of Health An Orphan Products Board the House of Representatives the National Organization for Rare Disorders Office NORD Human Services New Federal NIH OFFICE OF RARE the Orphan Drug Act the Office of Rare Dis-

H. R. 4013 Duchenne H. R. 4013—3 Lou Gehrig’s Crohn H. R. 4013—4 H. R.

rare diseases rare institutes office rare orphan diseases national institutes diseases disorders institutes health disorders orphan drugs national research excellence director shall centers